Evidence map›Paper›PMID 42598610›Full record

ReviewThe Malaysian journal of medical sciences : MJMS2026

Prevalence of Myopia in Children and Adolescents: A Systematic Review of Malaysian Prevalence Studies.

Eudocia Shu Yi Tan, Puneet Agarwal, Cheong Lieng Teng

Abstract readReview
In one paragraph

Review in The Malaysian journal of medical sciences : MJMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eudocia Shu Yi TanMinistry of Health Malaysia, Putrajaya, Malaysia.
Puneet AgarwalDepartment of Ophthalmology, IMU University, Seremban, Negeri Sembilan, Malaysia.
Cheong Lieng TengDepartment of Family Medicine, IMU University, Seremban, Negeri Sembilan, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Myopia is a common eye problem that has increased in prevalence worldwide, including in Malaysia. This study aimed to determine the prevalence of myopia among children and adolescents aged 0 to 18 years in Malaysia and its associated sociodemographic factors. Methods: The preferred reporting items for systematic reviews and meta-analyses (PRISMA) guideline were used in this study. We searched PubMed and Scopus, supplemented by a targeted Google Scholar search, for studies published from 1990 to 2024 on the prevalence of myopia in Malaysia. Myopia was defined as a refractive error ≥ -0.50 D. Results: The meta-analysis included 14 quality-assessed studies from seven states in Malaysia, covering 13,367 children and adolescents. The overall pooled prevalence of childhood myopia from 1990 to 2024 was 17.18% (95% CI: 9.98, 25.86). The prevalence of myopia was notably lower among children aged 0 to 6 years at 2.54% (95% CI: 0.66, 5.60) than among children aged 7 to 12 years at 26.48% (95% CI: 17.29, 36.84) and adolescents aged 13 to 18 years at 42.71% (95% CI: 26.80, 59.44). The prevalence of myopia was higher in females than in males (odds ratio: 1.20; 95% CI: 1.09, 1.32). The Chinese population had the highest prevalence of myopia at 44.62% (95% CI: 35.94, 53.47) compared with other ethnicities. Conclusion: Our findings indicate that at least four in 10 children and adolescents aged 13 to 18 years are likely to have myopia in Malaysia. Targeted clinical and public health interventions should prioritise high-risk groups, particularly females, individuals of Chinese ethnicity, and those aged 7 to 18 years.

Indexed as

adolescentchildrenMalaysiamyopiaprevalence

Identifiers

PMID42598610
PMCPMC13471979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.